(1)
She, Y.; Liu, Z. Effect of Peptide Drug Liraglutide Nano-Formulation Combined With Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients With Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes. Cell Mol Biol (Noisy-le-grand) 2022, 68, 221-228.